FinTrust Capital Advisors »

Silverback Therapeutics shares owned by FinTrust Capital Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by FinTrust Capital Advisors from 13F filings

Historical chart of FinTrust Capital Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by FinTrust Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by FinTrust Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 2.0k 10.22

More positions owned by FinTrust Capital Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Cr 5 10 Yr Etf (IMTB)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Ibonds 27 Trm Ts (IBTH)
Ishares Tr Ibonds 25 Trm Ts (IBTF)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Pimco Etf Tr Active Bd Etf (BOND)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Etf (IWB)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Ibonds Dec24 Etf (IBDP)

View all positions for FinTrust Capital Advisors

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Sr One Capital Management
Franklin Resources
Vanguard Group
BlackRock
K2 Principal Fund
Nextech Invest
State Street Corporation
FMR
Geode Capital Management
Perceptive Advisors
Rubric Capital Management
Royce & Associates

View all funds holding Silverback Therapeutics